Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge
/in Dendritic Cells, International Publications /von 2010-09-29 / Vaccine 2010 Nov;28(49):7764-73Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-28 / Vaccine 2010 Nov;28(49):7787-96Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-09-27 / J Transl Med 2010 Sep;8:89IFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models
/in Dendritic Cells, International Publications /von 2010-09-07 / Cancer Res. 2010 Sep;70(18):7093-101Dendritic cell vaccination of patients with metastatic colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-01 / Dan Med Bull 2010 Sep;57(9):B4171Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-09-01 / PLoS ONE 2010 Sep;5(9)Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma
/in Dendritic Cells, Endometrial Cancer, International Publications /von 2010-09-01 / Anticancer Res 2010 Sep;30(9):3709-14Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-08-24 / Clin. Cancer Res. 2010 Oct;16(20):5067-78Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2010-08-22 / Cancer Biol. Ther. 2010 Aug;10(4):368-75
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de